Methadone Market Size, Share, Global Industry Analysis, Latest Insights and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Methadone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the global methadone market size, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the methadone market?

The global methadone market size reached US$ 120.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 166.0 Million by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.

What is Methadone?

Methadone is a synthetic opioid used primarily for the treatment of opioid addiction and, in some instances, for pain management. It acts as a substitute for other opioids such as heroin or prescription painkillers, aiming to mitigate withdrawal symptoms and cravings. Methadone is administered under medical supervision, generally in specialized clinics, and comes in various forms such as tablets, liquid, and injectable solutions. It is long-acting, reducing the frequency of doses and allowing for more consistent levels of the drug in the body. Its medical administration allows for controlled tapering, facilitating opioid cessation while minimizing risks.

Request for a sample copy of this report: https://www.imarcgroup.com/methadone-market/requestsample

What are the growth prospects and trends in the methadone industry?

The rising opioid crisis represents a key factor driving the demand for methadone treatment programs worldwide. Advancements in research have facilitated the development of specialized methadone treatments that are tailored to the patient’s needs, enhancing its effectiveness. Additionally, there is a growing recognition of the importance of medically assisted treatments (MAT) in the fight against opioid addiction, propelling the acceptance and use of methadone. Public awareness campaigns on opioid addiction and treatment options also contribute to the increasing demand for methadone as a treatment solution. Online platforms and telehealth services have expanded access to methadone treatments, particularly in remote areas or for those who may find it difficult to attend in-person clinics. This broadened reach aids in combatting the opioid crisis on a global scale. Moreover, the focus on reducing the stigma associated with opioid addiction and its treatment is fostering a more supportive environment for the use of methadone. Other factors such as increasing healthcare spending, greater public awareness, and improvements in treatment protocols is further bolstering the growth of the methadone market globally.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Mode of Administration:

• Oral Medicine
• Injections

Breakup by Therapeutic Area:

• Pain Treatment
• Detoxification
• Maintenance Therapy

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Rehab Centers
• Drug Stores

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Mallinckrodt Pharmaceuticals
• Hikma Pharmaceuticals PLC
• VistaPharm Inc. (Pharmaceutical Associates Inc.)

Browse the full report with TOC and list of Figures: https://www.imarcgroup.com/methadone-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Article source: https://article-realm.com/article/Business/52875-Methadone-Market-Size-Share-Global-Industry-Analysis-Latest-Insights-and-Forecast-2023-2028.html